Media stories about Fresenius Medical Care Corporation (NYSE:FMS) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Fresenius Medical Care Corporation earned a daily sentiment score of 0.24 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.1805885023199 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the news headlines that may have effected Accern Sentiment’s analysis:

Fresenius Medical Care Corporation (FMS) opened at 45.70 on Thursday. The firm has a 50 day moving average price of $48.16 and a 200 day moving average price of $44.57. Fresenius Medical Care Corporation has a 52 week low of $38.05 and a 52 week high of $50.22. The stock has a market capitalization of $28.05 billion, a P/E ratio of 19.96 and a beta of 0.47.

Fresenius Medical Care Corporation (NYSE:FMS) last posted its earnings results on Tuesday, August 1st. The company reported $0.48 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.53 by $0.05. The company had revenue of $4.47 billion for the quarter, compared to the consensus estimate of $5.20 billion. Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same period last year, the company posted $0.96 earnings per share. Equities research analysts predict that Fresenius Medical Care Corporation will post $3.12 earnings per share for the current year.

A number of research analysts recently issued reports on the company. Nord/LB restated a “buy” rating on shares of Fresenius Medical Care Corporation in a research note on Wednesday, June 28th. Royal Bank Of Canada reiterated a “hold” rating and issued a $44.00 target price on shares of Fresenius Medical Care Corporation in a research note on Wednesday, July 5th. UBS AG reiterated a “sell” rating on shares of Fresenius Medical Care Corporation in a research note on Tuesday, July 4th. Zacks Investment Research upgraded Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a research note on Tuesday, July 11th. Finally, BidaskClub downgraded Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $48.67.

ILLEGAL ACTIVITY WARNING: “Fresenius Medical Care Corporation (FMS) Earning Somewhat Positive Media Coverage, Report Finds” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.watchlistnews.com/fresenius-medical-care-corporation-fms-earning-somewhat-positive-media-coverage-report-finds/1467132.html.

About Fresenius Medical Care Corporation

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Insider Buying and Selling by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.